CSIMarket Company Name, Ticker, Competitors, else..
 
Nabriva Therapeutics Plc  (NASDAQ: NBRV)
Other Ticker:  
 
 

NBRV's Market share relative to its competitors, as of Q2 2023

As of Q2 2023 (Revenue in Millions of $)

Date modified: 2025-03-14T02:45:57+00:00



COMPANY NAME REVENUES
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months
Q2 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE
A Quarter Before
Q1 2023
Nabriva Therapeutics Plc 29.56 10.67% 3.97 % 7.26 %
Bioxcel Therapeutics Inc 2.28 0.82% 0.38% 1.06%
Jaguar Health Inc 10.48 3.78% 5.50% 2.60%
Scynexis Inc 3.75 1.35% 1.73% 0.63%
Theravance Biopharma inc 64.38 23.24% 33.17% 16.14%
Paratek Pharmaceuticals Inc 166.64 60.14% 55.25% 72.30%
SUBTOTAL 277.08 100% 56.53 100%



NBRV's Market share relative to its competitors, as of Q2 2023 within the Major Pharmaceutical Preparations Industry
As of Q2 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months Ending
Q1 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE

Q1 2023
Nabriva Therapeutics Plc 10.67% 13.07% 3.97 % 7.26 %
Bioxcel Therapeutics Inc 0.82% 0.86% 0.38% 1.06%
Jaguar Health Inc 3.78% 3.65% 5.50% 2.60%
Scynexis Inc 1.35% 3.07% 1.73% 0.63%
Theravance Biopharma inc 23.24% 21.96% 33.17% 16.14%
Paratek Pharmaceuticals Inc 60.14% 57.39% 55.25% 72.30%
SUBTOTAL 100% 100% 100% 100%



NBRV's Market share relative to its competitors, as of Q2 2023 within the Healthcare Sector
As of Q2 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months Ending
Q1 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE

Q1 2023
Nabriva Therapeutics Plc 10.67% 13.07% 3.97 % 7.26 %
Bioxcel Therapeutics Inc 0.82% 0.86% 0.38% 1.06%
Jaguar Health Inc 3.78% 3.65% 5.50% 2.60%
Scynexis Inc 1.35% 3.07% 1.73% 0.63%
Theravance Biopharma inc 23.24% 21.96% 33.17% 16.14%
Paratek Pharmaceuticals Inc 60.14% 57.39% 55.25% 72.30%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Nabriva Therapeutics Plc's market divisions, geographic dispersion, segments, products, and services, visit Nabriva Therapeutics Plc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com